cardiovascular disease
Acute coronary syndromes: new guideline for diagnosis and management
A new guideline represents a significant advance in the diagnosis and management of people with suspected or confirmed acute coronary syndromes. By Karalyn Huxhagen BPharm, FPS, CredPharm (MMR), consultant pharmacist Learning …
Lipid-lowering therapies
Lowering low-density lipoprotein (LDL) cholesterol is crucial for reducing the risk of atherosclerotic cardiovascular disease and subsequent cardiovascular events. Pharmacists play a significant role in managing this by promoting adherence …
Fibre supplementation for managing blood lipids
This article summarises the potential benefits of fibre supplementation as part of a novel approach to managing blood lipids, and the role pharmacists can play in recommending fibre supplements to …
Sick day management of medicines
Sick day management of medicines is a vital but often overlooked component of safe pharmacotherapy. Pharmacists are critically positioned to lead this initiative through medication reviews, point-of-care counselling, and interprofessional …
The role of omega-3 in cardiovascular disease
Pharmacists are well placed to discuss the risk of cardiovascular disease (CVD) with patients, and provide advice on diet and lifestyle, including the importance of consuming omega-3 in the diet. …
Research Roundup
Debbie Rigby rounds up the latest in research news Frailty and Exacerbation of Chronic Obstructive Pulmonary Disease Frail patients with COPD have a more unfavourable future risk of acute exacerbations …
Research roundup
Debbie Rigby rounds up the latest in research news Heart failure with comorbid dementia One-fifth of persons over age 65 with HF also have comorbid dementia. Co-occurring HF and dementia …
Research roundup
Debbie Rigby takes a look at the latest research news Evidence supporting the choice of a new cardiovascular risk equation for Australia The Australian CVD risk assessment and management guideline, …
Diabetes Updates
‘Cholesterol complacency’ call to action For the first time in nearly a decade, new data highlights the potential extent of the cholesterol problem among high-risk patents costing the economy $1.5 …
Community pharmacist prescribing: $4.4 billion in savings
A pharmacist intervention for patients at high risk of cardiovascular disease both improves patient outcomes and saves money, according to new research Pharmacist researchers from Canada have developed a model …
How much sleep is too much?
Getting enough sleep is important… but getting too much could be risky, new research shows A study of more than 116,000 people in seven regions of the world, published in …
Looking at the numbers
Reports show 19 deaths occurred due to sildenafil in the UK last year. What does this mean for the medicine, which is being considered for S3 status in Australia? Data from …